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ABSTRACT 
 
 
Objective: To conduct a systematic review and meta-analysis of randomised control trials 
that examined the effect of walking on risk factors for cardiovascular disease. 
Methods: Four electronic databases and reference lists were searched (Jan 1971–June 2012). 
Two authors identified randomised control trials of interventions > 4 weeks duration that 
included at least one group with walking as the only treatment and a no-exercise comparator 
group. Participants were inactive at baseline. Pooled results were reported as weighted mean 
treatment effects and 95% confidence intervals using a random effects model. 
Results: 32 articles reported the effects of walking interventions on cardiovascular disease 
risk factors. Walking increased aerobic capacity (3.04mL/kg/min, 95% CI 2.48 to 3.60) and 
reduced systolic (-3.58mmHg, 95% CI -5.19 to -1.97) and diastolic (-1.54mmHg, 95% CI -
2.83 to -0.26) blood pressure, waist circumference (-1.51cm, 95% CI -2.34 to -0.68) , weight 
(-1.37kg, 95% CI -1.75 to -1.00), percentage body fat (-1.22%, 95% CI -1.70 to -0.73) and 
body mass index  (-0.53kg/m
2
, 95% CI -0.72 to -0.35) but failed to alter blood lipids. 
Conclusions: Walking interventions improve many risk factors for cardiovascular disease.  
This underscores the central role of walking in physical activity for health promotion.  
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INTRODUCTION  
Physical inactivity is the fourth leading cause of global mortality (World Health 
Organisation, 2009) responsible for 6-10% of the major non-communicable diseases of 
coronary heart disease, type 2 diabetes, and breast and colon cancer (Lee et al., 2012). Whilst 
sport, running and vigorous gym based exercise are often seen as counter measures, walking 
offers a natural, widely accepted, low cost, low injury risk (Hootman et al., 2001), 
environmentally friendly approach to physical activity which can be incorporated into 
activities of daily living and/or undertaken recreationally. Walking is also likely to be more 
accessible and suitable to a considerable portion of the higher-risk population who may be 
obese, sedentary, at high risk of cardiovascular disease and for whom strenuous forms of 
exercise may be unsuitable. Walking at a self-selected pace is moderate intensity for most 
adults (Ainsworth et al., 2000; Murtagh et al., 2002). Indeed it is estimated that walking at 
3mph would be vigorous intensity for approximately 20% of the population (Kelly et al., 
2011). Systematic reviews have indicated that inactive people can be encouraged to walk 
more by tailored interventions (Ogilvie et al., 2007) and the National Institute for Health and 
Clinical Excellence have recently produced guidelines to promote walking for travel and 
recreational purposes (National institute for Health and Clinical Excellence, 2012).  
 
Whilst it is unsurprising that walking has become a cornerstone of physical activity 
promotion strategies, a challenge faced by healthcare professionals and patients is knowing 
the effects of walking on health, especially as many published walking interventions employ 
relatively small samples and findings are often inconsistent between studies. Conversely, the 
use of meta-analysis increases the precision and accuracy of the estimates of the effects of 
walking, quantifies the inconsistency between studies and enhances generalizability to a 
larger population. We previously reported a meta-analysis of walking interventions published 
up to 2004, that included aerobic fitness, blood pressure, and body composition (Murphy et 
al., 2007). Since then there has been an increase in the number of published interventions 
examining the effects of walking on risk factors for cardiovascular disease. In addition, an 
increased range of outcome measures have been included in these studies, such as blood 
lipids and several measures of adiposity.  While there is now greater evidence of the 
concomitant dangers of these factors to public health (Physical Activity Guidelines Advisory 
Committee, 2008) a recent comprehensive synthesis of evidence from randomised control 
trials on the effect of walking on health is lacking. This updated meta-analysis therefore 
expands our understanding of the treatment-effect relationship between walking and health.  
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The objective of this study was to assess the effect of walking interventions on risk factors for 
cardiovascular disease in previously inactive adults. This updates our previous review and 
provides healthcare professionals with a synthesis of the effects accruing when inactive adults 
undertake a walking programme. 
 
METHODS 
We followed the PRISMA statement (preferred reporting items for systemic reviews and 
meta-analyses) in conducting and reporting the meta-analysis (Moher et al., 2009).  A review 
protocol has not been published separately. 
 
Data sources and searches 
The following electronic databases were searched: PubMed, Web of Science, ScienceDirect 
and the Cochrane Central Register of Controlled Trials. In addition, we hand-searched 
reference lists from review and original articles. Authors were contacted, if necessary, to 
confirm eligibility criteria. The following search terms were used: walking, exercise, health, 
cardiovascular risk. Date limits of Sept 2004 – Sept 2012 were applied. 
 
Study selection 
The study selection process is summarised in figure 1. Initial eligibility assessment was 
performed by one author by reviewing the title and abstracts. The full text versions of 48 
articles were then reviewed independently by two authors. Disagreements between reviewers 
were resolved by consensus by reassessing each of the eligibility criteria for the study. 
 
The following eligibility criteria were used: randomised, controlled trials studying the effect 
of walking on one or more cardiovascular risk factors; trials with at least one group who 
completed walking as the only intervention;  training for a minimum of four weeks; no-
exercise control group; participants aged 18 years or older who were reported as being 
apparently sedentary but otherwise healthy at baseline; selected cardiovascular disease risk 
factors assessed pre- and post-intervention (or change from pre- to post-intervention 
reported); English language articles published in peer-reviewed journals between January 
1971 and June 2012. 
 
Data extraction and quality assessment 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
5 
 
We used a modified version of the data extraction sheet developed for the previous meta-
analysis. Two individuals extracted the data from included studies and a second author 
checked the extracted data. Disagreements were resolved by consensus. Two of the selected 
studies were suspected to be reports from the same participants - this was confirmed by 
contacting the authors. The authors of eight articles were contacted for further information 
(Aldred and Rohalu, 2011; Baker et al., 2008; Osei-Tutu and Campagna, 2005; Stensel et al., 
1994; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011). All 
responded and provided numerical data (Aldred and Rohalu, 2011; Osei-Tutu and Campagna, 
2005; Tully et al., 2005; Tully et al., 2007) or clarifications regarding the study protocol 
(Aldred and Rohalu, 2011; Baker et al., 2008; Stensel et al., 1994; Stensel et al., 1993) that 
were not detailed in the published paper.  Previously unpublished numerical data was 
obtained from the original researchers of three articles (Osei-Tutu and Campagna, 2005; 
Tully et al., 2005; Tully et al., 2007). 
 
The previous meta-analysis extracted data on: 
1) Participant characteristics (age, sex, number of men and women) 
2) Intervention characteristics (duration, frequency, intensity of walking, duration of the 
intervention)  
3) Outcome measures (aerobic fitness, body weight, body fat percentage, body mass index, 
systolic blood pressure and diastolic blood pressure). 
4) Study design 
 
In addition to the above items, the following outcome measures were extracted from all 
included studies: total cholesterol, HDL cholesterol, LDL cholesterol, waist circumference, 
waist-to-hip ratio.  
 
The Cochrane Collaboration „risk of bias‟ assessment tool was employed.  Two authors, with 
adequate reliability, evaluated studies for sequence generation, allocation concealment, 
blinding, incomplete outcome data, selective outcome reporting and other potential threats to 
validity (Higgins et al., 2011).  
 
Data synthesis and statistical analysis 
Treatment effect was calculated by subtracting pre-intervention mean from the post-
intervention mean (post – pre) for both exercise (delta 1) and control (delta 2) groups.  
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Treatment effect was then obtained as delta 1 – delta 2 for each study.  Six studies reported 
data on standard deviation of change between pre- and post-intervention measurements 
(Butcher et al., 2008; Murphy and Hardman, 1998; Murphy et al., 2006; Tully et al., 2005; 
Tully et al., 2007; Woolf-May et al., 2011).  If not reported, standard deviation of the 
individual delta values were calculated using pre- and post- standard deviations and the mean 
pre/post correlation from studies which reported sufficient detail to calculate correlation 
(Higgins JPT et al., 2011).  To assess the effect of this assumption, sensitivity analyses were 
performed using minimum and maximum available pre-post correlations.  In trials that had 
more than two intervention arms the description of the interventions  were checked to ensure 
they only varied in the level of exercise undertaken and if so all intervention arms were 
collapsed into a single treatment arm (Higgins JPT and Deeks JJ, 2011).   
 
Seven studies reported weight and height as outcomes but did not report body mass index 
(Braith et al., 1994; Duncan et al., 1991; Hinkleman and Nieman, 1993; Moreau et al., 2001; 
Osei-Tutu and Campagna, 2005; Santiago et al., 1995; Woolf-May et al., 2011).  For these 
studies, an approximation for the mean and standard deviation of body mass index was 
derived using formulae for the product and ratio of random variables (Stuart and Ord, 1987). 
A sensitivity analysis was performed on the body mass index outcome by including and 
excluding these approximated data.  Similarly, waist-to-hip ratio was approximated using 
separately reported waist and hip circumference data from the three studies (Anderson et al., 
2006; Murtagh et al., 2005; Serwe et al., 2011).  
 
Pooled results were reported as weighted mean treatment effects and 95% confidence 
intervals using a random effects model (DerSimonian and Laird method(DerSimonian and 
Laird, 1986)).  Statistical heterogeneity was evaluated using the I
2
 statistic.  Publication bias 
was appraised by visual inspection of the funnel plots of treatment effect against standard 
error (to identify asymmetry, which can indicate evidence of non-publication of small trials 
with negative results) and also by Egger‟s test (Egger et al., 1997). To investigate possible 
sources of heterogeneity across studies we performed a meta-regression analysis to 
investigate the effects of the following study specific characteristics on treatment effect: 
mean age of participants, mean pre-intervention weight, gender (proportion of male 
participants) and duration of intervention. A p-value <0.05 was considered statistically 
significant.  All analyses were conducted using Stata, Version 12 (StataCorp, College Station, 
TX).  
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RESULTS 
 
Study selection 
A total of 210 articles were identified by electronic searches and 16 articles from hand-
searching. Thirty one duplicates were then excluded. After reviewing the title and abstract of 
the 195 articles identified, 150 were excluded as they did not meet the inclusion criteria. The 
full text versions of 45 articles were then reviewed. Fifteen studies were deemed eligible for 
inclusion in the study and combined with studies reported in our previous meta-analysis 
(Murphy et al., 2007) (n=17). Therefore in total 32 articles are included in this systemic 
review and updated meta-analysis. See figure 1 for further information. Two articles reported 
different outcomes measures from the same subjects in a larger study (Stensel et al., 1994; 
Stensel et al., 1993) and so the results from these two articles were combined to represent one 
study in the meta-analysis. 
 
Study characteristics 
All studies selected for this review are randomised controlled trials published in English.  
Subject and intervention characteristics are summarised in table 1. Participates ranged in age 
from 30 to 83 years. Sixteen studies include females only, 14 included both males and 
females and three included males only. The mean length of the walking interventions was 
18.7 weeks (range: 8 – 52 weeks). Duration of walking per day was 20 – 60 minutes on 2 – 7 
days per week. Twenty one studies reported exercise intensity as either percentage of 
maximum heart rate (range: 56-86 % HRmax), percentage of VO2max or VO2peak (45-62%), or 
percentage heart rate reserve (54-85 %). Using the generally accepted definition of moderate 
intensity exercise as 64-76% HRmax / 46-63% VO2max / 40-59% HRR (Ewing Garber et al., 
2011), 19 of these studies included a moderate intensity walking group (Aldred et al., 1995; 
Aldred and Rohalu, 2011; Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 
2002b; Duncan et al., 1991; Hamdorf and Penhall, 1999; Hinkleman and Nieman, 1993; Jette 
et al., 1988; Murphy and Hardman, 1998; Murtagh et al., 2005; Osei-Tutu and Campagna, 
2005; Probart et al., 1991; Ready et al., 1995; Ready et al., 1996; Santiago et al., 1995; 
Stensel et al., 1994; Stensel et al., 1993; Woolf-May et al., 1999).  Three studies incorporated 
a vigorous intensity (Ewing Garber et al., 2011) walking group (Braith et al., 1994; Duncan et 
al., 1991; Serwe et al., 2011) and three studies included a light intensity group (Asikainen et 
al., 2002a; Duncan et al., 1991; Murphy et al., 2006).  Additionally, five studies reported that 
walking was self-paced (Bell et al., 2010; Butcher et al., 2008; Moreau et al., 2001; Morgan 
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et al., 2010; Simons and Andel, 2006) and four noted that walking intensity was at a brisk 
pace (Baker et al., 2008; Brandon and Elliott-Lloyd, 2006; Tully et al., 2005; Tully et al., 
2007). It was a criterion for inclusion that studies included a no-exercise control group. All 
authors were contacted to confirm the data extracted in the study characteristics table and 
responses were received from the authors of 21 articles. 
 
Table 2 describes the number of studies and participants and summary baseline values for all 
outcome measurements.  Also shown in this table are the weighted mean treatment effect and 
its 95% confidence interval, % change from baseline, I
2
 and Egger‟s test bias coefficients.  
For each outcome there is a separate appendix containing a table of results from the 
individual studies pooled, a forest plot and a funnel plot (appendices 1 – 11).  Appendix 12 
details the results of meta-regression analyses of treatment effect against mean age of 
participants, mean pre-intervention weight, proportion of male participants and duration of 
intervention.  A summary of the effect of the walking intervention on each outcome variable 
is given below. 
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Table 1: Characteristics of included studies examining the effect of walking interventions on risk factors for cardiovascular disease 
 
 Participants Details of Intervention  
Groups n Age (mean 
± SD) 
Sex No. of 
weeks 
Duration 
(min/session) 
Freq 
(days/wk) 
Intensity 
 
Notes 
 
Jette et al. (1988) walk 13  14m 12f   30 3 60% VO2max   
 con 13       
Duncan et al. (1991) stroll 18 20-40 f 24 60 5 56%  HRmax  
brisk 12    45 5 67%  HRmax  
aerobic 16    36 5 86%  HRmax  
con 13        
Probart et al. (1991) walk 10 72.0 ± 1.9 f 26 20 3 70%  HRmax  
con 6 72.0 ± 1.7       
Hinkleman and 
Nieman (1993) 
walk 18 36.0 ± 6.8 f 15 45 5 62 ± 2 % VO2max   
con 18 32.4 ± 6.4       
Braith et al. (1994) mod 19 66.0 ± 5.0 mf 26 45  3 70HRR Duration increased by 5 mins every 2 weeks until 40 minutes. Weeks 
14 – 26: 45 mins for mod and 35 for high intensity group. Both groups 
progressed to 70% HRR by week 8. Mod group continued at 70% for 
last 13 weeks. The high group progressed to 80-85HRR for last 13 
weeks. 
high 14 65.0 ± 4.0   35 3 80-85HRR 
con 11 66.0 ± 5.0      
Stensel et al. (1994); 
Stensel et al. (1993) 
walk 42 50.3 ± 5.2 m 52 28 7 68%  HRmax  
con 23 51.6 ± 4.8       
Aldred et al. (1995) walk 11 49.6 ± 4.7 f 12 33  5.6  74%  HRmax Duration of sessions progressed from 24 ± 1 to 33 ± 1 by week12. 
Number of sessions progressed from 3.5 ± 0.3 to 5.6 ± 0.3 by week 12. 
Mean age for walk group is for the 13 subject who began the study. 
con 13 49.1 ± 4.7 f     
Ready et al. (1995) walk 15 60.9 ± 4.6 
(group mean) 
f 24 54.3 ± 7.7 4.9 54% HRR  
con 10        
Santiago et al. 
(1995) 
walk 16 30.1 ± 5.3 f 40  4 72%  HRmax 4.8 km x 4 times per week. Progressive programme: wk 3-10: 5.1 kph 
walk at 5% grade (68% HRmax); wk 11-25: 5.4 kph walk at 6% grade 
(71% HRmax); wk 26-40: 5.8 kph  walk at 7% grade (76% HRmax).  
con 11 31.5 ± 6.1      
Ready et al. (1996) 3 day 19 61.3 ± 5.8 
(group mean) 
f 24 60 3 60% VO2peak  
5 day 17   60 5   
con 20        
Murphy and 
Hardman (1998) 
 
 
 
short 12 44.8 ± 8.4 f 10 3x10 5 73%  HRmax  
long 12 48.0 ± 5.5   30 5 75%  HRmax  
con 10 47.3 ± 4.1       
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 Participants Details of Intervention  
Groups n Age (mean 
± SD) 
Sex No. of 
weeks 
Duration 
(min/session) 
Freq 
(days/wk) 
Intensity 
 
Notes 
 
Hamdorf and 
Penhall (1999) 
walk 18 82.4 ± 2.8 f 26 25  2 73%  HRmax Duration increased progressively (1 min/week) from 5 minutes during 
the first week to 25 minutes by week 22 
con 20 83.1 ± 3.1      
Woolf-May et al. 
(1999) 
LW 19 50.1 ± 6.3 mf 18 34.8 ± 1.0 4.4 ± 0.3 73.4 ± 4.8 %  HRmax Frequency of session noted is number of sessions per week 
IW 10 57.7 ± 6.1   14.5 ± 0.8 10.6 ± 1.2 74.8 ± 3.8 %  HRmax 
SW 14 54.3 ± 7.4   9.9 ± 0.3 15.4 ± 1.2 74.6 ± 4.1 %  HRmax 
 con 13 54.7 ± 7.0      
Moreau et al. (2001) walk 15 53.0 ± 7.8 f 24  7 self-paced Goal to increase activity by 3km every day of the week 
con 9 55.0 ± 3.0       
Asikainen et al. 
(2002a) 
walk 1 20 57.0 ± 3.8 f 24 54.0 ± 5.6 5 55%  VO2max Mean (SD) age is for subjects numbers at pre-test: W1=21, W2=21, 
W3=18 and W4= 21, Control = 40 
walk 2 21 55.0 ± 3.7   65.0 ± 7.8 5 45%  VO2max 
walk 3 16 54.0 ± 3.5   38.0 ± 3.9 5 55%  VO2max 
walk 4 21 55.0 ± 4.2   46.0 ± 6.2 5 45%  VO2max 
con 38 56.0 ± 3.8      
Asikainen et al. 
(2002b) 
single bout 44 57.8 ± 4.4 f 15 47.9 ± 14.2 5 65%  HRmax Daily sessions for accumulated bout groups were divided into  two 
equally long sessions with at least a 5 hour interval 
accum bout 43 57.6 ± 4.2   25.0 ± 3.2 5  
 con 43 56.5 ± 4.2      
Murtagh et al. 
(2005) 
single bout 16 45.7 ± 9.4 15m 17f 
  
  
12 20 3 73.1 ± 8.7 %  HRmax Mean age is for the 48 subjects who began the study. 
accum bout 9   2 x10  72.1 ± 7.7 %  HRmax  
con 7       
Osei-Tutu and 
Campagna (2005) 
long bout 15 35.1 ± 4.6 8m 7f 8 1x30 5 60-79  %  HRmax Progressive programme: wk 1: 30 mins x 3 days; wk2: 30 mins x 4 
days; wk 3-8:  30 mins x 5 days wk 
 
short bout 15 35.4 ± 8.3 8m 7f  3x10   
 con 10 31.6 ± 4.8 5m 5f     
Tully et al. (2005) walk 21 55.5 ± 4.0 9m 12f 12 30 5 brisk Mean age is for baseline subject numbers. 
con 10 57.8 ± 4.6 4m 6f      
Anderson et al. 
(2006) 
walk 10 38.1 ± 9.3 (all 
groups, n=37) 
f 8 30 5 74%  HRmax Additional group not included in meta-analysis. 
con 9       
Brandon and Elliott-
Lloyd (2006) 
walk AA 15 34.0 ± 7.2 f 18  3 brisk Instruction to walk as briskly as possible for 3 miles with goal of 3.5 
mph 
walk W 13 40.5 ± 7.1      
con AA 12 36.0 ± 8.4      
 
 
con W 12 42.0 ± 9.7       
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 Participants Details of Intervention  
Groups n Age (mean 
± SD) 
Sex No. of 
weeks 
Duration 
(min/session) 
Freq 
(days/wk) 
Intensity 
 
Notes 
 
Murphy et al. (2006) walk 21 41.4 ± 7.5 mf 8 45 2 62 ±  7.1 %  HRmax Progressive programme: wk 1: 25 min x 2 days; wk 2: 35 min x 2 
days; wk 3 – 8: 45 min x 2 days  
con 12 40.8 ± 10.0      
Simons and Andel 
(2006) 
walk 18 81.6 ± 3.3  7m 11f 16  2 self-paced The initial walk length and pace were determined at the beginning of 
the study based on a pre-assessment performance during a timed, 880-
yard walk. Participants encouraged to gradually increase the distance 
of their walks and reduce the elapsed time. 
con 21 84.0 ± 3.3 3m 18f     
Tully et al. (2007) 3 day 44 47.8 ± 6.0 21m 23f 12 30 3 brisk Participants could choose to complete their walking in a single bout, or 
in multiple bouts of at least 10 minutes. 
Intention-to-treat analysis performed, substituting baseline data for 
those at 12 weeks for the participants who withdrew during the study. 
5 day 42 46.4 ± 4.8 16m 26f  30 5  
con 20 49.1 ± 6.3 5m 15f     
Baker et al. (2008) walk 39 47.3 ± 9.3 8m 31f 12   Brisk Goal to increase steps by 3,000 on at least 5 days/wk. 
Intention to treat analysis conducted. 
con 40 51.2 ± 7.9 8m 32f     
Butcher et al. (2008) walk 17 44.9 ± 10.0 9m 8f 8  3 self-paced 10,000 steps 3 times a week on treadmill 
con 17 46.1 ± 12.2 9m 8f      
Bell et al. (2010) walk 43 m: 49 ± 11; f: 
50 ±  9 
mf 24  7 self-paced Progressive increase to 9221 ± 1429 steps per day by wk 17 
con 45       
Morgan et al. (2010) walk 14 57.4 ± 6.5 3m 11f 15  7 self-paced Progressive increase to 10,000 steps per day by wk 3 and maintained 
for additional 12 weeks 
con 15 62.1 ± 4.0 4m 11f     
Aldred and Rohalu 
(2011) 
walk 12 68.1 ± 2.6 6m 6f 8 30 3 50% Wmax   
con 9 67.7 ± 2.9 4m 5f      
Serwe et al. (2011) SB 20 38.2 ± 7.3 f 8 30 5 60-70 HRR  
LB 20 37.1 ± 7.2   10 x 3    
con 20 36.3 ± 8.1       
Woolf-May et al. 
(2011) 
walk 29 54.9 ± 8.0 m 24 25.1 ± 10.3 7.2 ± 2.9 65.2 ± 6.9 % HRmax Frequency of session noted is number of sessions per week 
con 19 52.4 ± 8.0 m     
 
Abbreviations: Accum = accumulated, AA=African American, Con = control group, f = female, HRmax = maximum heart rate, HRR = heart rate reserve, IW = intermediate 
walkers, LW = long walkers, m = males, mins = minutes, mod = moderate, SW = short walkers, VO2max = maximal oxygen consumption, VO2peak = peak oxygen 
consumption, W = White, walk = walk group, Wmax = maximal performance 
Databases were searched for articles published between Jan 1971 and June 2012. 
Note: Subject numbers are those included in the analysis unless otherwise stated. 
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Table 2: Pre-intervention mean (SD) and weighted mean treatment effect by outcome 
 
 
 
 
 
 
  
 Pooled analysis  Heterogeneity Egger’s test 
Outcome No. of 
studies 
No. of 
participants 
Mean (SD) Weighted 
mean TE 
(95% CI) p % 
change 
I
2 
(%) p Bias 
coefficient 
p 
VO2max (ml/kg/min) 18 894 29.02 (5.19) 3.04 (2.48 to 3.60) <0.001 10.5 71 <0.001 0.47 0.45 
BMI (kg/m2) 23 1,201 27.15 (5.01) -0.53 (-0.72 to -0.35) <0.001 -2.0 70 <0.001 -1.56 0.005 
Systolic BP (mm Hg) 16 816 124.66 (14.50) -3.58 (-5.19 to -1.97) <0.001 -2.9 39 0.05 -0.91 0.29 
Diastolic BP (mm Hg) 16 806 77.54 (9.52) -1.54 (-2.83 to -0.26) 0.02 -2.0 29 0.13 -0.60 0.63 
Total cholesterol (mmol/L) 16 758 5.58 (1.07) -0.12 (-0.27 to 0.04) 0.14 -2.2 42 0.04 -0.09 0.94 
HDL cholesterol (mmol/L) 15 725 1.35 (0.47) 0.01 (-0.04 to 0.07) 0.65 0.7 0 0.47 0.05 0.95 
LDL cholesterol (mmol/L) 14 664 3.72 (1.00) -0.05 (-0.17 to 0.07) 0.39 1.3 0 0.59 0.22 0.79 
Waist circumference (cm) 11 574 90.56 (14.15) -1.51 (-2.34 to -0.68) <0.001 -1.7 38 0.10 2.27 0.02 
Waist-to-hip ratio 14 706 0.85 (0.10) -0.01 (-0.02 to 0.00) 0.07 -1.2 60 0.001 1.04 0.28 
Body weight (kg) 25 1,275 75.40 (14.75) -1.37 (-1.75 to -1.00) <0.001 -1.8 66 <0.001 -1.75 0.001 
Body fat (%) 14 719 34.29 (6.07) -1.22 (-1.70 to -0.73) <0.001 -3.5 68 <0.001 -0.78 0.38 
VO2max = maximal oxygen consumption, BMI = body mass index 
Databases were searched for articles published between Jan 1971 and June 2012. 
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Aerobic fitness 
Observed VO2max, predicted VO2max and VO2peak were utilised as the outcome measure of 
aerobic fitness.  Twelve studies reported VO2max (Aldred and Rohalu, 2011; Asikainen et al., 
2002a; Asikainen et al., 2002b; Braith et al., 1994; Duncan et al., 1991; Hinkleman and 
Nieman, 1993; Jette et al., 1988; Murphy and Hardman, 1998; Osei-Tutu and Campagna, 
2005; Probart et al., 1991; Ready et al., 1995; Santiago et al., 1995),  four reported predicted 
VO2max (Brandon and Elliott-Lloyd, 2006; Butcher et al., 2008; Woolf-May et al., 1999; 
Woolf-May et al., 2011) and two reported VO2peak (Bell et al., 2010; Ready et al., 1996). 
There was a statistically significant improvement in VO2max of 3.04 mL/kg/min (95% CI 2.48 
to 3.60) in the participants who followed the walking intervention.   There was, however, 
evidence of significant heterogeneity between the results (I
2
=71%, p<0.001).  
 
Anthropometric measures 
Sixteen trials examined the effect of walking on body mass index (Aldred and Rohalu, 2011; 
Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 2002b; Baker et al., 2008; 
Bell et al., 2010; Brandon and Elliott-Lloyd, 2006; Butcher et al., 2008; Murphy et al., 2006; 
Probart et al., 1991; Ready et al., 1995; Ready et al., 1996; Serwe et al., 2011; Stensel et al., 
1994; Tully et al., 2005; Tully et al., 2007)  and a further seven trials reported height and 
weight, allowing body mass index to be approximated (Braith et al., 1994; Duncan et al., 
1991; Hinkleman and Nieman, 1993; Moreau et al., 2001; Osei-Tutu and Campagna, 2005; 
Santiago et al., 1995; Woolf-May et al., 2011).  The pooled effect of the walking intervention 
was a statistically significant reduction in body mass index of 0.53 kg/m
2 
(95% CI -0.72 to -
0.35).  A sensitivity analysis considering only those studies which reported body mass index 
directly as an outcome found a similar estimate of effect (0.49 kg/m
2
 reduction (95% CI -0.70 
to -0.27)). There was substantial heterogeneity between the studies (I
2
=70%, p<0.001).   The 
funnel plot showed some asymmetry indicating that smaller studies which found an increase 
in body mass index in the intervention group appeared to be absent (Egger's test, p=0.005).   
 
Eleven studies measured waist circumference (Anderson et al., 2006; Baker et al., 2008; Bell 
et al., 2010; Murphy and Hardman, 1998; Murphy et al., 2006; Murtagh et al., 2005; Ready et 
al., 1996; Serwe et al., 2011; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011). 
Overall a significant reduction of 1.51 cm (95% CI -2.34 to -0.68) was found when the 
studies were pooled.  The funnel plot showed some asymmetry indicating an absence of 
smaller studies (Egger‟s test, p=0.02). 
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Waist-to-hip ratio was an outcome in eleven trials (Aldred et al., 1995; Baker et al., 2008; 
Bell et al., 2010; Brandon and Elliott-Lloyd, 2006; Murphy et al., 2006; Ready et al., 1995; 
Ready et al., 1996; Stensel et al., 1994; Tully et al., 2005; Tully et al., 2007; Woolf-May et 
al., 2011)  and a further three trials gave enough information for this outcome to be 
approximated (Anderson et al., 2006; Murtagh et al., 2005; Serwe et al., 2011).  A small non-
significant reduction in waist-to-hip ratio of 0.01 (95% CI -0.02 to 0.00) was found.  A 
sensitivity analysis of only those trials directly reporting waist-to-hip ratio found a similar 
estimate of effect (-0.01 (95% CI -0.02 to 0.00)).  There was substantial heterogeneity 
between studies (I
2
=60%, p<0.001).   
 
Twenty-five studies presented data on body weight (Aldred et al., 1995; Aldred and Rohalu, 
2011; Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 2002b; Baker et al., 
2008; Bell et al., 2010; Braith et al., 1994; Brandon and Elliott-Lloyd, 2006; Butcher et al., 
2008; Duncan et al., 1991; Hinkleman and Nieman, 1993; Moreau et al., 2001; Murphy and 
Hardman, 1998; Murphy et al., 2006; Murtagh et al., 2005; Osei-Tutu and Campagna, 2005; 
Ready et al., 1995; Ready et al., 1996; Santiago et al., 1995; Serwe et al., 2011; Stensel et al., 
1994; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011). With the exception of 
one study (Baker et al., 2008), all reported a negative treatment effect (intervention group lost 
more or gained less weight than the control group).  Pooling of the data resulted in an overall 
reduction in body weight of 1.37 kg (95% CI -1.75 to -1.00) in those participating in a 
walking intervention. There was significant heterogeneity between studies (I
2
=66%, 
p<0.001).  Meta-regression analyses found that studies of only female participants had a 
greater overall treatment effect (-1.96 kg, (95% CI -2.52 to -1.37)) than those studies 
including some male participants (-0.71 kg (95% CI -1.04 to -0.37)), although substantial 
heterogeneity remained for the female only studies.  There was also evidence of publication 
bias indicating that studies reporting a positive treatment effect (greater weight gain in the 
treatment group) may be less likely to reach publication.  
 
Data for the effect of walking on body fat percentage was available from fourteen trials 
(Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 2002b; Baker et al., 2008; 
Brandon and Elliott-Lloyd, 2006; Butcher et al., 2008; Duncan et al., 1991; Hinkleman and 
Nieman, 1993; Moreau et al., 2001; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 
1995; Santiago et al., 1995; Stensel et al., 1994). Pooling of these data found an overall 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
15 
 
reduction in body fat of 1.22% (95% CI -1.70 to -0.73).   There was substantial heterogeneity 
between studies (I
2
=68%, p<0.001).   
  
Blood pressure 
The weighted mean treatment effect of the sixteen trials which measured systolic blood 
pressure (Baker et al., 2008; Bell et al., 2010; Braith et al., 1994; Brandon and Elliott-Lloyd, 
2006; Butcher et al., 2008; Duncan et al., 1991; Hamdorf and Penhall, 1999; Murphy and 
Hardman, 1998; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1996; Serwe et al., 
2011; Simons and Andel, 2006; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) 
was -3.58 mmHg (95% CI -5.19 to -1.97) indicating a reduction in systolic blood pressure in 
those who followed a program of walking.  Diastolic blood pressure was also reported by 
sixteen studies (Baker et al., 2008; Bell et al., 2010; Braith et al., 1994; Brandon and Elliott-
Lloyd, 2006; Butcher et al., 2008; Duncan et al., 1991; Hamdorf and Penhall, 1999; Moreau 
et al., 2001; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1996; Serwe et al., 2011; 
Simons and Andel, 2006; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) and 
the weighted mean treatment effect of the walking intervention was a significant reduction of 
1.54 mmHg (95% CI -2.83 to -0.26).   
 
Lipids 
Data on the effect of walking on total cholesterol were available from sixteen studies (Baker 
et al., 2008; Bell et al., 2010; Butcher et al., 2008; Duncan et al., 1991; Hinkleman and 
Nieman, 1993; Morgan et al., 2010; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 
1995; Ready et al., 1996; Santiago et al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully 
et al., 2007; Woolf-May et al., 1999; Woolf-May et al., 2011), HDL cholesterol from fifteen 
studies (Baker et al., 2008; Bell et al., 2010; Butcher et al., 2008; Duncan et al., 1991; 
Morgan et al., 2010; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1995; Ready et 
al., 1996; Santiago et al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; 
Woolf-May et al., 1999; Woolf-May et al., 2011), and LDL cholesterol from fourteen studies 
(Bell et al., 2010; Butcher et al., 2008; Duncan et al., 1991; Hinkleman and Nieman, 1993; 
Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1995; Ready et al., 1996; Santiago et 
al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 1999; 
Woolf-May et al., 2011).  None of the pooled treatment effects for blood lipid outcomes were 
statistically significant.  There was no evidence of publication bias, nor was any between-
study heterogeneity found. 
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For all outcomes, sensitivity analyses to assess the impact of the correlation coefficient used 
for imputing standard deviation of change score did not result in any variation in significance 
of the pooled treatment effect.  Similarly, meta-regression analyses were conducted to assess 
whether heterogeneity could be explained by age, baseline weight, gender or duration of 
intervention.  With the exception of body weight, where a gender effect was found to explain 
some of the heterogeneity, the majority of the slope parameters were found to be non-
significant (see appendix 12).   
 
Risk of bias of individual studies 
Details of the risk-of-bias assessment appear in Table 3.  Only two studies were judged to be 
at low risk of bias.  Many studies did not provide sufficient information to make firm 
judgements about bias.  
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Table 3. Assessment of risk of bias 
Trial 
Adequate sequence 
generation? 
Allocation 
concealment? 
Blinding? 
Incomplete 
outcome data 
addressed? 
Free of 
selective 
reporting? 
Free of other 
bias? 
Jette et al. (1988) Unclear Unclear Unclear Yes Yes Yes 
Duncan et al. (1991) Unclear Unclear Unclear No Yes Yes 
Probart et al. (1991) Unclear Unclear Unclear Yes Yes Yes 
Hinkleman and Nieman (1993) Unclear Unclear Unclear No Yes Yes 
Braith et al. (1994) Unclear Unclear Unclear Unclear Yes Yes 
Stensel et al. (1994); Stensel et al. 
(1993) 
Unclear Unclear Unclear Yes Yes Yes 
Aldred et al. (1995) Unclear Unclear Unclear Yes Yes Yes 
Ready et al. (1995) Unclear Unclear Unclear Yes Yes Yes 
Santiago et al. (1995) Yes Yes Unclear Yes Yes Yes 
Ready et al. (1996) Unclear Unclear Unclear No Yes Yes 
Murphy and Hardman (1998) Unclear Unclear Unclear Yes Yes Yes 
Hamdorf and Penhall (1999) Yes Yes Unclear Yes Yes Yes 
Woolf-May et al. (1999) Unclear Unclear No Unclear Yes Yes 
Moreau et al. (2001) Unclear Unclear No Yes Yes Yes 
Asikainen et al. (2002a) Yes Yes No Yes Yes Yes 
Asikainen et al. (2002b) Unclear Unclear Unclear Yes Yes No 
Murtagh et al. (2005) Unclear Unclear Unclear Yes Yes Yes 
Osei-Tutu and Campagna (2005) Unclear Unclear No Yes Yes Yes 
Tully et al. (2005) Yes Yes Yes  Yes Yes Yes 
Anderson et al. (2006) Yes Unclear Unclear Yes Yes Yes 
Brandon and Elliott-Lloyd (2006) Unclear Unclear Unclear Unclear Yes Yes 
Murphy et al. (2006) Unclear Unclear Unclear Yes Yes Yes 
Simons and Andel (2006) Unclear Unclear Yes Yes Yes Yes 
Tully et al. (2007) Yes Yes No Yes Yes Yes 
Baker et al. (2008) Yes Yes Yes Yes Yes Yes 
Butcher et al. (2008) Unclear Unclear Unclear Yes Yes Yes 
Bell et al. (2010) Unclear Unclear Unclear Yes Yes Yes 
Morgan et al. (2010) Unclear Unclear Unclear Yes Yes Yes 
Aldred and Rohalu (2011) Unclear Unclear Unclear Unclear No Yes 
Serwe et al. (2011) Unclear Unclear No Yes Yes Yes 
Woolf-May et al. (2011) Yes Yes Unclear Unclear Yes Yes 
Databases were searched for articles published between Jan 1971 and June 2012. 
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DISCUSSION 
This updated systematic review and meta-analysis suggests that walking programmes 
improve several markers of cardiovascular risk, including aerobic capacity, systolic and 
diastolic blood pressure, and adiposity (waist circumference, body mass, percentage body fat 
and body mass index) in previously inactive but apparently healthy adults.  However there 
was no evidence of changes in total cholesterol, HDL cholesterol, LDL cholesterol or waist-
to-hip ratio. In this updated meta-analysis we analysed five additional outcome variables not 
included in our earlier publication (Murphy et al., 2007), namely total cholesterol, HDL 
cholesterol, LDL cholesterol, waist-to-hip ratio and waist circumference, and identified an 
additional 15 relevant studies. Overall, this body of evidence supports the role of walking as a 
central feature of individual and population health promoting strategies to ameliorate the 
escalating global burden of cardiovascular disease. 
 
Aerobic fitness 
Aerobic fitness is an independent risk factor for cardiovascular disease and a stronger risk 
factor than physical activity alone (Blair et al., 2001; Blair and Jackson, 2001). VO2max, 
considered the “gold standard” for the assessment of aerobic fitness (Murphy et al., 2007), 
was measured or predicted in 18 of the studies included and showed a significant weighted 
mean treatment effect (TE) of 3.04 ml/kg/min. Consequences of improvement in aerobic 
capacity include greater ease of performance of everyday physical activities and improved 
quality of life for the individual (Murphy et al., 2007). From a population perspective an 
improvement of this magnitude (approx 10%) is likely to result in a 15% reduction in 
mortality (Dunn et al., 1999), irrespective of the baseline fitness level (Blair et al., 1995). 
Healthcare professionals should be mindful however that walking needs to be of at least 
moderate intensity (64-76% HR max) (American College of Sports Medicine, 2010) in order 
to improve aerobic fitness . Evidence has demonstrated that even greater fitness 
improvements can be attained from walking at vigorous intensity (Duncan et al., 1991; 
Nicklas et al., 2009). 
 
Blood pressure 
Hypertension is a major risk factor for cardiovascular disease (Egan et al., 2010). A 
significant reduction in systolic blood pressure of 3.58mm Hg and in diastolic blood pressure 
of 1.54 mm Hg was observed in this meta-analysis. This weighted mean treatment effect is 
similar to findings of an earlier meta-analysis focussing on walking and resting blood 
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pressure (Kelley et al., 2001). A previous prospective study reported that a 2mm Hg 
reduction in systolic blood pressure would result in 10%  lower stroke mortality and 7%  
lower mortality from ischaemic heart disease or other vascular causes in middle age 
(Prospective Studies Collaboration, 2002),  thus highlighting the clinical significance of even 
small changes in resting blood pressure. Given that hypertension has wide-scale population 
prevalence, affecting approximately 19 – 32% of men and women in UK (Maryon-Davis, 
2005) and 29% of US adults (Egan et al., 2010), policy makers should consider the central 
role walking could play in population blood pressure control strategies. 
 
Lipids 
Elevated total cholesterol levels have been associated with coronary heart disease mortality 
(Menotti and Lanti, 2003) and also found to be independently predictive of ischemic heart 
disease (Yarnell et al., 2001). In the current review 16 studies reported total cholesterol and a 
non-significant weighted mean treatment effect of - 0.12 mmol/L was found. The weighted 
mean treatment effect for HDL cholesterol of 0.01 mmol/L did not reach statistical 
significance, which may be linked to the optimal mean pre-intervention values of these 
subjects (Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in 
Adults, 2001). While HDL cholesterol levels are strongly, independently and inversely 
associated with coronary heart disease (Cooney et al., 2009), evidence from a systematic 
review and regression analysis suggests that simply increasing the amount of circulating HDL 
cholesterol does not reduce the risk of coronary heart disease events, coronary heart disease 
deaths, or total deaths (Briel et al., 2009). Existing evidence supports reduction in LDL 
cholesterol as the primary goal for lipid modifying interventions (Briel et al., 2009; Expert 
Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001). 
LDL cholesterol was reported in 14 studies in this meta-analysis, however the mean TE of -
0.05 mmol/L was not significant. Some authors have suggested that changes in 
apolipoprotiens A or B  may reduce cardiovascular risk by increasing the LDL-C particle size 
without changing LDL levels and therefore monitoring apolipoproteins rather than just the 
cholesterol of lipoproteins might be a more sensitive measure of exercise induced changes in 
lipoprotein function (Holme et al., 2007).  
 
Anthropometric measures 
Obesity is a major influence on the development of cardiovascular diseases (Kumanyika et 
al., 2008). Several measures of overweight and obesity were utilised in the studies included in 
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this review and significant effects were observed for body mass, percentage body fat, body 
mass index and waist circumference.  The mean decrease in body mass and percentage body 
fat of 1.37kg and 1.22% respectively was significant and reinforces the critical role that 
walking can play in the management of overweight. Body mass index, a strong predictor of 
overall mortality both above and below the apparent optimum of about 22.5–25 kg/m2 
(Prospective Studies Collaboration, 2009), demonstrated a TE of  -0.53 km/m
2
. Waist 
circumference, which may be the best single indicator of other individual and multiple 
cardiovascular risk factors (Dobbelsteyn et al., 2001), also demonstrated a significant TE of -
1.51cm. Although the treatment effect observed in waist circumference may be small, a 
previous meta-regression analysis of prospective studies demonstrated that a 1cm increase in 
waist circumference was associated with a 2% increase in the relative risk of a cardiovascular 
disease event (de Koning et al., 2007). So even small improvements in waist circumference 
resulting from walking interventions may have substantial public health gains. 
 
Limitations 
While this meta-analysis provides useful updated information for healthcare providers and 
policy-makers, the results should be interpreted with the following limitations in mind. First, 
this meta-analysis pooled data from several studies in order to calculate mean weighted 
treatment effects. However the walking intervention employed, in terms of dose of exercise 
and support provided, is not the same across studies. Second, risk of bias, assessed using the 
Cochrane Collaboration assessment tool (Higgins et al., 2011), revealed that many studies did 
not provide sufficient information to make firm judgements about bias. Third, observed 
changes in cardiovascular risk factors may be mediated by a change in another risk factor. 
For example change in VO2max measured per unit of body mass may be affected by change in 
body mass therefore the impact of the intervention on a single outcome measure is difficult to 
isolate. Fourth, the search strategy was restricted to English-language publications. Fifth, 
several studies did not fully report outcomes of interest and not all authors who were 
contacted for further information provided missing data. Additionally, for many of the studies 
standard deviation of change from baseline was not reported and these data were imputed 
using the mean correlation coefficient from the available data.  Sensitivity analyses were 
performed using a range of correlation coefficients which did not show any changes to the 
pooled effect sizes. Sixth, publication bias was evident for some outcomes including body 
mass index, weight and waist circumference. Asymmetrical funnel plots suggested that there 
was an absence of small studies with negative findings (favouring the control group). Finally 
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the majority of subjects in the studies were middle-aged and female. While this may reflects 
the appeal that this form of physical activity has for women (Murphy et al., 2007), the 
applicability of these findings to a male populations may therefore be limited.  
 
Conclusions 
Our findings confirm the important role that regular walking can play in the prevention of 
cardiovascular disease. The meta-analysis revealed positive changes for multiple 
cardiovascular disease risk factors, including aerobic fitness, systolic and diastolic blood 
pressure, and several measures of adiposity in previously inactive adults who walked as part 
of a randomised controlled trial. Clinicians and health-care providers can prescribe walking 
with confidence that it will evoke health benefit. As in our previous meta-analysis, few 
studies have investigated the effects of walking interventions on non-traditional 
cardiovascular disease risk factors, such as markers of inflammation, oxidative stress and 
coagulation (Murphy et al., 2007). Future research should incorporate these measures and 
further examine the effect of walking in specific populations including ethnic minorities and 
older adults. The results and recommendations of this meta-analysis are of relevance for 
health professionals involved in the primary prevention of cardiovascular disease and should 
underscore the central role of walking as a cornerstone in physical activity for health 
promotion.  
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Figure 1: Study selection process 
 
 
 
Databases were searched for articles published between Jan 1971 and June 2012. 
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Highlights 
 
 32 RCTs examining the effect of walking on risk factors for cardiovascular disease were included. 
 Walking improved aerobic fitness (10.5%), systolic (-3%) and diastolic blood pressure (-2%).  
 Walking improved several measures of adiposity but did not alter blood lipids significantly. 
